LBPH - Margin operasi Longboard

Logo perusahaan publik Longboard Pharmaceuticals (LBPH)

Longboard Pharmaceuticals focuses on developing therapies for rare epilepsies through the activation of 5-HT2C receptors. The current operating margin confirms the strength of this strategic direction, with the 0.00 mark reflecting the latest data. The business is based on the development of current drugs in clinical trial phases and demonstrates high resilience to macroeconomic shocks due to the non-cyclical nature of the biopharmaceutical sector.

LBPH: Margin operasi Longboard Pharmaceuticals, Inc. 04.07.2022 - 07.12.2024

Rincian analitis perusahaan Longboard Pharmaceuticals

Analisis dhasar perusahaan:Longboard, LBPH
Barang utama Longboard

To objectively evaluate the issuer, it is essential for the manager to understand the operating margin, which measures the share of profit from core business operations in total revenue before taxes and interest. An analysis of the operating profitability of operational processes, with a current value of 0.00, demonstrates effective cost management, which is critically important for Longboard Pharmaceuticals (LBPH) when developing costly drugs for the treatment of rare pediatric neurological pathologies.

Analisis perusahaan pesaing

Margin dodolan operasi BIIB|NBIX: Tingkat bathi operasi|Rentabilitas operasi Regencell Bioscience Ltd (RGC)|Margin operasi axsome.com (AXSM)|Margin operasi ACAD (acadia-pharm.com)|XENE - Margin dodolan operasi|vikingtherapeutics.com - Margin operasi|Supernus Pharma (SUPN) - Margin dodolan operasi|CPRX: Margin operasi|Denali Therapeutics Inc. (DNLI) - Margin operasi|Rentabilitas operasi Harmony Pharma|Rentabilitas operasi BHVN|Margin dodolan operasi AMLX (Amylyx Pharmaceuticals, Inc.)|Margin dodolan operasi Trevi Corp TRVI|Rentabilitas operasi praxismedicines.com PRAX|AVXL - Margin dodolan operasi|CeriBell EEG - Margin operasi|Rentabilitas dodolan operasi prothena.com|Alector Therapeutics (ALEC) - Rentabilitas operasi|Annexon Biosciences Inc. - Tingkat bathi operasi|OMER (Omeros Corp) - Margin operasi|Margin operasi neurogene.com|Margin operasi ACIU|VYGR - Rentabilitas dodolan operasi|Rentabilitas operasi Neumora Therapeutics Inc NMRA|Rentabilitas kegiatan operasi Scilex Holding Co. (SCLX)|TVGN - Rentabilitas operasi|Rentabilitas dodolan operasi alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Margin dodolan operasi|IKT: Rasio bathi operasi|Rentabilitas operasi Cassava Sciences, Inc.|ASRT (assertiotx.com) - Rasio bathi operasi|Rentabilitas operasi Coya (COYA)|VTGN - Rentabilitas dodolan operasi|Margin operasi OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Rentabilitas dodolan operasi|cervomed.com - Margin operasi|Tingkat bathi operasi ATHE (Alterity Therapeutics Limited)|CLNN: Margin operasi|Margin dodolan operasi PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Margin operasi|Rentabilitas dodolan operasi Relmada Therapeutics Inc RLMD|Rentabilitas operasi Annovis Bio Corporation (ANVS)|GRCE - Rentabilitas dodolan operasi|Rentabilitas operasi Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Rentabilitas dodolan operasi|NeuroSense Therapeutics, Ltd. - Margin operasi|RVPH: Rentabilitas operasi|MTVA: Margin operasi|NRXS - Rentabilitas kegiatan operasi|HSDT (Helius Medical Technologies Inc.) - Margin operasi|Rentabilitas dodolan operasi Passage Bio PASG|Rentabilitas operasi Neuphoria (NEUP)|Margin operasi Minerva Neurosciences Corp (NERV)|Rentabilitas operasi Athira ATHA|Margin operasi Addex ADXN|Alzamend - Margin operasi|Rentabilitas dodolan operasi Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Rentabilitas operasi|KTTA: Rasio bathi operasi|Margin dodolan operasi CRGT|Avenue Therapeutics, Inc - Margin bathi operasi|Rentabilitas operasi Brainstorm Cell (BCLI)|CARA: Margin bathi operasi|Chromocell Therapeutics Corp. - Margin dodolan operasi|Rentabilitas kegiatan operasi Eliem (ELYM)|ITCI: Margin dodolan operasi|Tingkat bathi operasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Margin dodolan operasi|Margin dodolan operasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Margin operasi|Neurotrope - Margin bathi operasi|Margin operasi TRVN|Rentabilitas kegiatan operasi Vigil Neuroscience, Inc.|Rentabilitas operasi Anew Medical, Inc. WENA|CERE - Margin dodolan operasi